Descriptio
Alpellaib medium 1,1,1, trifluaro-2- (IV-methylpytridin-II-yl) propanol, cas non. 1396893-43-8. Molecular formula huius groundbreaking compositis est C9H10F3No et eius M. pondus est 205.18.
Nostrum Alpellaib medium est a key ingrediens in synthesis Alpellaib, a breakthrough anti-cancer medicamento ad curatio hormone receptor-positivum, humana epidermal incrementum factor receptor II-negans provectus pectus cancer. Nostra mediis ludere a vitalis munus in productione Alpellaib et sunt magni momenti pars chemical synthesis processus.
Eligere nobis
JDK owns primi-genus productio facilities et qualitas procuratio paratus, quod assures firmum copia API intermedia. Pro team amen dico r & D ex uber. In utroque nos investigatione CMO & CDMmo in domesticis et International forum.




![Tofacitinib medium 1,4-chloro-VII-p-toluenesulfonyl, 7h Pyrrolo [2,3-d] Pyimidine cas No. 479633-63-1](https://cdnus.globalso.com/biohealthjdk/1.14-Chloro-7-p-toluenesulfonyl-7H-pyrrolo-23-d-pyrimidine.jpg)

